Malaria breakthrough hope rekindled by pandemic research after 30 years of stagnation

The vaccine race that took place during the Covid-19 pandemic led to the birth of several new technologies and products that could also pave the way for a breakthrough within the development of an effective malaria vaccine. As the World Health Organization marks World Malaria Day, MedWatch takes a deep dive into the state of affairs within malaria vaccine research.

by albert rønning-andersson, translated by daniel pedersen

Developing the Covid-19 vaccines in such a short period of time was an unprecedented feat of the pharmaceutical industry.

In record-breaking time, new production facilities, technologies and, not least, impressive results were established, the fruit of which might now be able pave the way for a vaccine against malaria, the mosquito-borne disease that costs the lives of more than half a million people, predominantly children, each year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today